eptifibatide
- Product NDC
- 25021-408
- 11-digit product format
- 250210408
- Labeler code
- 25021
- Product ID
- 25021-408_7e4a3720-9c2e-4fb7-b703-f896f7fd0686
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- eptifibatide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA204693
- Marketing category
- ANDA
- Marketing start
- 2018-07-15
- Substance
- EPTIFIBATIDE
- Active strength
- .75 mg/mL
- Pharmacologic classes
- Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- eptifibatide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EPTIFIBATIDE | .75 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NA8320J834 |
| Rxcui | 200349, 1736470 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 25021-408-51 | eptifibatide | 100 mL in 1 VIAL | INJECTION, SOLUTION | 100 | | 6 |
| 25021-408-51 | eptifibatide | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 25021-408 | EPTIFIBATIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 6 | Current NDC, Legacy NDC, 2 package rows | 20241024_a0d18778-0194-461a-a4ea-b2fca5df57c3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-408-51 | 25021040851 | 1 VIAL in 1 CARTON (25021-408-51) / 100 mL in 1 VIAL | 1 vial | 2018-07-15 | 0000-00-00 | No | No | Current |